News
HCWB
0.7731
-3.43%
-0.0275
Weekly Report: what happened at HCWB last week (1102-1106)?
Weekly Report · 6d ago
HCW Biologics Inc. Secures up to $10.0 Million in Cash Through Debt Financing
NASDAQ · 11/06 04:58
HCW Biologics Secures Debt Financing to Support Clinical Development
TipRanks · 11/05 14:33
HCW Biologics Announces It Secured $10M In Cash To Finance Its Phase 1 Trial Of HCW9302 To Treat Alopecia Areata
Benzinga · 11/05 13:47
Weekly Report: what happened at HCWB last week (1026-1030)?
Weekly Report · 11/02 10:07
Weekly Report: what happened at HCWB last week (1019-1023)?
Weekly Report · 10/26 10:07
Weekly Report: what happened at HCWB last week (1012-1016)?
Weekly Report · 10/19 10:07
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/13 12:05
Weekly Report: what happened at HCWB last week (1005-1009)?
Weekly Report · 10/12 10:12
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 10/10 16:40
Weekly Report: what happened at HCWB last week (0928-1002)?
Weekly Report · 10/05 10:11
HCW Biologics (HCWB) Receives a Buy from Maxim Group
TipRanks · 10/03 11:46
HCW Biologics registers to sell 1.81M shares of common stock for holders
TipRanks · 10/02 20:40
HCW Biologics Files Prospectus For Resale Of Up To 1,807,228 Shares Underlying Armistice Capital Warrants
Benzinga · 10/02 20:33
Weekly Report: what happened at HCWB last week (0921-0925)?
Weekly Report · 09/28 10:07
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/25 21:05
HCW Biologics Announces Strategic $1.5 Million Financing
TipRanks · 09/24 13:34
HCW Biologics prices 903,614 units at $1.6599 in private placement
TipRanks · 09/24 12:45
HCW Biologics Prices $1.5M Private Placement Of 903,614 Units At $1.6599 Per Unit
Benzinga · 09/24 12:28
Press Release: HCW Biologics Announces Pricing of $1.5 Million Private Placement
Dow Jones · 09/24 12:25
More
Webull provides a variety of real-time HCWB stock news. You can receive the latest news about Hcw Biologics Inc. through multiple platforms. This information may help you make smarter investment decisions.
About HCWB
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.